Immuneering Corporation (IMRX)
NASDAQ: IMRX · Real-Time Price · USD
2.110
+0.070 (3.43%)
At close: Nov 21, 2024, 4:00 PM
2.102
-0.008 (-0.39%)
After-hours: Nov 21, 2024, 5:46 PM EST

Immuneering Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2023 FY 2022 FY 2021 FY 2020 FY 2019
Period Ending
Nov '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
Market Capitalization
63215128426--
Market Cap Growth
-67.15%67.99%-69.91%---
Enterprise Value
1612216267--
Last Close Price
2.117.354.8516.17--
PS Ratio
--404.05204.62--
PB Ratio
1.142.381.172.73--
P/TBV Ratio
1.462.581.252.86--
EV/Sales Ratio
--49.59128.17--
Debt / Equity Ratio
0.070.050.040.030.020.35
Asset Turnover
--0.000.020.09-
Quick Ratio
7.3210.9213.1026.5316.6627.69
Current Ratio
7.9911.3513.5027.0416.7327.83
Return on Equity (ROE)
-71.81%-53.36%-38.00%-35.01%-74.56%-
Return on Assets (ROA)
-42.35%-32.46%-22.38%-20.65%-40.66%-
Return on Capital (ROIC)
-45.31%-34.81%-23.43%-21.44%-42.85%-
Earnings Yield
-92.81%-24.86%-39.44%-7.88%--
FCF Yield
-83.93%-22.92%-35.02%-7.26%--
Buyback Yield / Dilution
-6.64%-7.69%-93.84%-175.00%0.00%-
Total Shareholder Return
-6.64%-7.69%-93.84%-175.00%0.00%-
Source: S&P Capital IQ. Standard template. Financial Sources.